YOURAM NASSIR, MD

MD

Hematology & Oncology Physician

NPI: 1114977071IndividualAccepts Medicare

Specialties, Licenses & Credentials

Hematology & Oncology PhysicianPrimary

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

A64603(CA)

CMS Specialties

PrimaryHEMATOLOGY

Additional

INTERNAL MEDICINE

Education

UNIVERSITY OF CALIFORNIA, GEFFEN SCHOOL OF MEDICINE

Class of 1996

Research & Publications (4)

Bortezomib, ascorbic acid and melphalan (BAM) therapy for patients with newly diagnosed multiple myeloma: an effective and well-tolerated frontline regimen.

PMID 19226361·Eur J Haematol·2009

3-trial

A phase I study of samarium lexidronam/bortezomib combination therapy for the treatment of relapsed or refractory multiple myeloma.

PMID 19188182·Clin Cancer Res·2009

3-trial

Zoledronic acid markedly improves bone mineral density for patients with monoclonal gammopathy of undetermined significance and bone loss.

PMID 18829511·Clin Cancer Res·2008

3-trial

Safety and efficacy of bortezomib and melphalan combination in patients with relapsed or refractory multiple myeloma: updated results of a phase 1/2 study after longer follow-up.

PMID 18463870·Ann Hematol·2008

3-trial

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address: 5901 W OLYMPIC BLVD STE 505
LOS ANGELES, CA 90036
Phone: (323) 930-2324

Quick Facts

NPI: 1114977071
Entity Type: Individual
Gender: Male
Medicare: Accepted
Specialties: 1
Locations: 1
Years in Practice: 30
Publications: 4

Are you this provider?

Claim Your Profile